Basic & Clinical Medicine ›› 2015, Vol. 35 ›› Issue (6): 846-850.
Previous Articles Next Articles
Yi-Lin LI1, 1,Bing XING
Received:
Revised:
Online:
Published:
Contact:
Abstract: Somatostatin analogs are the mainstay of medical therapy for growth hormone-secreting pituitary adenomas. They can inhibit the growth hormone secretion in pituitary gland and the proliferation of tumor cells. However, some patients get unsatisfying curative effect because of drug resistance. The mechanisms of somatostatin analog resistance mainly are related to somatostatin receptor, downstream signaling pathways, histopathology, adhesion molecule and other factors.
Key words: growth hormone-secreting pituitary adenomas, acromegaly, somatostatin analog, resistance
CLC Number:
R736.4
Yi-Lin LI Bing XING. Research progress on mechanisms of resistance to somatostatin analogs in growth hormone-secreting pituitary adenomas[J]. Basic & Clinical Medicine, 2015, 35(6): 846-850.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/
http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2015/V35/I6/846